S&P 500   3,612.61 (-0.71%)
DOW   29,574.19 (-1.12%)
QQQ   297.74 (-0.42%)
AAPL   118.92 (+2.00%)
MSFT   212.16 (-1.43%)
FB   273.83 (-1.43%)
GOOGL   1,753.01 (-1.90%)
AMZN   3,145.77 (-1.55%)
TSLA   584.33 (-0.24%)
NVDA   526.44 (-0.76%)
BABA   265.50 (-3.97%)
CGC   29.03 (+0.10%)
GE   10.25 (-1.44%)
MU   64.72 (+0.76%)
AMD   90.85 (+4.20%)
T   28.91 (-0.41%)
NIO   51.62 (-4.41%)
F   9.12 (+0.33%)
ACB   11.27 (+7.64%)
NFLX   484.94 (-1.31%)
BA   212.78 (-1.72%)
GILD   60.11 (+0.13%)
DIS   147.36 (+0.16%)
S&P 500   3,612.61 (-0.71%)
DOW   29,574.19 (-1.12%)
QQQ   297.74 (-0.42%)
AAPL   118.92 (+2.00%)
MSFT   212.16 (-1.43%)
FB   273.83 (-1.43%)
GOOGL   1,753.01 (-1.90%)
AMZN   3,145.77 (-1.55%)
TSLA   584.33 (-0.24%)
NVDA   526.44 (-0.76%)
BABA   265.50 (-3.97%)
CGC   29.03 (+0.10%)
GE   10.25 (-1.44%)
MU   64.72 (+0.76%)
AMD   90.85 (+4.20%)
T   28.91 (-0.41%)
NIO   51.62 (-4.41%)
F   9.12 (+0.33%)
ACB   11.27 (+7.64%)
NFLX   484.94 (-1.31%)
BA   212.78 (-1.72%)
GILD   60.11 (+0.13%)
DIS   147.36 (+0.16%)
S&P 500   3,612.61 (-0.71%)
DOW   29,574.19 (-1.12%)
QQQ   297.74 (-0.42%)
AAPL   118.92 (+2.00%)
MSFT   212.16 (-1.43%)
FB   273.83 (-1.43%)
GOOGL   1,753.01 (-1.90%)
AMZN   3,145.77 (-1.55%)
TSLA   584.33 (-0.24%)
NVDA   526.44 (-0.76%)
BABA   265.50 (-3.97%)
CGC   29.03 (+0.10%)
GE   10.25 (-1.44%)
MU   64.72 (+0.76%)
AMD   90.85 (+4.20%)
T   28.91 (-0.41%)
NIO   51.62 (-4.41%)
F   9.12 (+0.33%)
ACB   11.27 (+7.64%)
NFLX   484.94 (-1.31%)
BA   212.78 (-1.72%)
GILD   60.11 (+0.13%)
DIS   147.36 (+0.16%)
S&P 500   3,612.61 (-0.71%)
DOW   29,574.19 (-1.12%)
QQQ   297.74 (-0.42%)
AAPL   118.92 (+2.00%)
MSFT   212.16 (-1.43%)
FB   273.83 (-1.43%)
GOOGL   1,753.01 (-1.90%)
AMZN   3,145.77 (-1.55%)
TSLA   584.33 (-0.24%)
NVDA   526.44 (-0.76%)
BABA   265.50 (-3.97%)
CGC   29.03 (+0.10%)
GE   10.25 (-1.44%)
MU   64.72 (+0.76%)
AMD   90.85 (+4.20%)
T   28.91 (-0.41%)
NIO   51.62 (-4.41%)
F   9.12 (+0.33%)
ACB   11.27 (+7.64%)
NFLX   484.94 (-1.31%)
BA   212.78 (-1.72%)
GILD   60.11 (+0.13%)
DIS   147.36 (+0.16%)
Log in
NYSE:MDT

Medtronic Stock Forecast, Price & News

$114.31
-0.28 (-0.24 %)
(As of 11/30/2020 12:16 PM ET)
Add
Compare
Today's Range
$113.07
Now: $114.31
$114.50
50-Day Range
$100.57
MA: $108.39
$114.56
52-Week Range
$72.13
Now: $114.31
$122.15
Volume121,023 shs
Average Volume5.67 million shs
Market Capitalization$153.66 billion
P/E Ratio34.96
Dividend Yield2.02%
Beta0.64
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Read More
Medtronic logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 3.3Dividend Strength: 4.2Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.69 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP58505510
Phone353-1438-1700
Employees90,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$28.91 billion
Cash Flow$7.38 per share
Book Value$37.96 per share

Profitability

Net Income$4.79 billion

Miscellaneous

Outstanding Shares1,344,215,000
Market Cap$153.66 billion
Next Earnings Date2/16/2021 (Estimated)
OptionableOptionable
$114.31
-0.28 (-0.24 %)
(As of 11/30/2020 12:16 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MDT News and Ratings via Email

Sign-up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Medtronic (NYSE:MDT) Frequently Asked Questions

How has Medtronic's stock been impacted by COVID-19 (Coronavirus)?

Medtronic's stock was trading at $92.44 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MDT shares have increased by 22.9% and is now trading at $113.59.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Medtronic?

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 1 sell rating, 3 hold ratings, 20 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Medtronic
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Medtronic?

Wall Street analysts have given Medtronic a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Medtronic wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Medtronic's next earnings date?

Medtronic is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021.
View our earnings forecast for Medtronic
.

How were Medtronic's earnings last quarter?

Medtronic plc (NYSE:MDT) posted its earnings results on Monday, November, 23rd. The medical technology company reported $1.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.80 by $0.22. The medical technology company had revenue of $7.65 billion for the quarter, compared to analysts' expectations of $7.05 billion. Medtronic had a return on equity of 10.47% and a net margin of 15.80%. During the same period in the prior year, the business earned $0.45 earnings per share.
View Medtronic's earnings history
.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic declared a quarterly dividend on Tuesday, August 25th. Stockholders of record on Friday, September 25th will be given a dividend of $0.58 per share on Friday, October 16th. This represents a $2.32 dividend on an annualized basis and a yield of 2.04%. The ex-dividend date of this dividend is Thursday, September 24th.
View Medtronic's dividend history
.

What price target have analysts set for MDT?

25 analysts have issued 12-month price targets for Medtronic's stock. Their forecasts range from $92.00 to $138.00. On average, they anticipate Medtronic's stock price to reach $122.00 in the next twelve months. This suggests a possible upside of 7.4% from the stock's current price.
View analysts' price targets for Medtronic
.

Who are some of Medtronic's key competitors?

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), The Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), The Home Depot (HD) and Walmart (WMT).

Who are Medtronic's key executives?

Medtronic's management team includes the following people:
  • Dr. Omar S. Ishrak, Exec. Chairman (Age 64, Pay $5.2M)
  • Mr. Geoffrey Straub Martha, CEO & Director (Age 50, Pay $1.68M)
  • Ms. Karen L. Parkhill, Exec. VP & CFO (Age 55, Pay $1.81M)
  • Mr. Bradley E. Lerman, Sr. VP, Gen. Counsel & Corp. Sec. (Age 64, Pay $1.74M)
  • Mr. Michael J. Coyle, Exec. VP and Group Pres of Cardiac & Vascular Group (Age 58, Pay $2.09M)
  • Mr. Mark Ploof, Sr. VP of Global Operations and Bus. Services
  • Dr. Richard E. Kuntz, Sr. VP & Chief Medical and Scientific Officer (Age 63)
  • Mr. Sean Lennon, Chief Information Officer
  • Mr. Ryan Weispfenning, VP of Investor Relations
  • Ms. Carol A. Surface, Sr. VP & Chief HR Officer (Age 54)

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Who are Medtronic's major shareholders?

Medtronic's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.34%), State Street Corp (4.31%), Massachusetts Financial Services Co. MA (3.76%), Wells Fargo & Company MN (1.11%), Morgan Stanley (0.77%) and Sanders Capital LLC (0.57%). Company insiders that own Medtronic stock include Bradley E Lerman, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, Hooman Hakami, Karen L Parkhill, Michael J Coyle, Omar Ishrak, Richard H Anderson, Richard Kuntz and Robert John White.
View institutional ownership trends for Medtronic
.

Which institutional investors are selling Medtronic stock?

MDT stock was sold by a variety of institutional investors in the last quarter, including CIBC Private Wealth Group LLC, Caisse DE Depot ET Placement DU Quebec, Neuberger Berman Group LLC, Allianz Asset Management GmbH, State Street Corp, UBS Asset Management Americas Inc., Robeco Institutional Asset Management B.V., and AQR Capital Management LLC. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Carol A Surface, Hoedt Rob Ten, Karen L Parkhill, Omar Ishrak, and Robert John White.
View insider buying and selling activity for Medtronic
.

Which institutional investors are buying Medtronic stock?

MDT stock was bought by a variety of institutional investors in the last quarter, including Coho Partners Ltd., BlackRock Inc., Nuveen Asset Management LLC, Polar Capital LLP, Morgan Stanley, Pendal Group Limited, AJO LP, and Schafer Cullen Capital Management Inc. Company insiders that have bought Medtronic stock in the last two years include Karen L Parkhill, Omar Ishrak, and Richard H Anderson.
View insider buying and selling activity for Medtronic
.

How do I buy shares of Medtronic?

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $113.59.

How big of a company is Medtronic?

Medtronic has a market capitalization of $152.69 billion and generates $28.91 billion in revenue each year. The medical technology company earns $4.79 billion in net income (profit) each year or $4.59 on an earnings per share basis. Medtronic employs 90,000 workers across the globe.

What is Medtronic's official website?

The official website for Medtronic is www.medtronic.com.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at 353-1438-1700 or via email at [email protected]

This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.